Guides palliative care consultation timing and symptom management integration with curative therapy. Use when integrating palliative care, managing cancer symptoms, or coordinating concurrent curative and palliative treatment.
Guides palliative care consultation timing and symptom management integration with curative therapy.
The landmark Temel et al. study (NEJM, 2010) demonstrated that early palliative care integration in metastatic NSCLC improved survival by 2.7 months compared to standard oncologic care alone. ASCO published a provisional clinical opinion in 2012 (updated 2017) stating that combined standard oncology care and palliative care should be considered early in the course of illness for patients with metastatic cancer and/or high symptom burden. Despite this evidence, palliative care is still frequently initiated only at end of life.
NCCN Palliative Care guidelines recommend palliative care consultation for any patient with serious illness, significant symptom burden, or distress regardless of disease stage. CMS quality measures and CoC standards increasingly incorporate palliative care referral metrics. Late palliative care referral is associated with higher healthcare costs, more aggressive end-of-life care, decreased quality of life, and worse caregiver bereavement outcomes.
ASCO/NCCN triggers for palliative care referral:
Document the specific trigger(s) for palliative care consultation and the date identified.
Use validated tools for systematic symptom assessment:
Edmonton Symptom Assessment System (ESAS) — assess 0–10 for each:
Symptom management priorities by prevalence in advanced cancer:
| Symptom | Prevalence | First-Line Approach |
|---|---|---|
| Pain | 60–90% | WHO analgesic ladder; see managing-cancer-pain skill |
| Fatigue | 60–90% | Exclude reversible causes (anemia, hypothyroid, depression); exercise prescription |
| Anorexia/Cachexia | 50–80% | Nutritional counseling; megestrol acetate or dexamethasone for appetite stimulation |
| Dyspnea | 30–70% | Opioids (low-dose morphine), fan therapy, supplemental O2 if hypoxic |
| Nausea | 30–60% | Identify cause (medication, obstruction, CNS, metabolic); targeted antiemetics |
| Constipation | 40–65% | Prophylactic bowel regimen with opioids; PEG-based laxatives first-line |
| Depression | 20–45% | Screen with PHQ-9; antidepressants + psychotherapy referral |
| Delirium | 20–40% | Identify and treat reversible causes; haloperidol for agitation if needed |
Palliative care is concurrent with, not a replacement for, disease-directed therapy:
For each palliative care encounter, document: